MedTrace Logo

Evaluation of CPP-ACP Prophylactic Effect on Enamel Surface During Orthodontic Treatment

NCT03187548 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2017-06-15

No results posted yet for this study

Summary

This study is aiming in preventing the formation of WSL associated with orthodontic treatment which occurs to more than 50% of orthodontically treated patients through applying CPP-ACP on the enamel surface once every 2 weeks for 3 months.

Conditions

  • White Spot Lesion
  • Enamel Hypomineralization

Interventions

DRUG

Casein Phosphopeptide-Amorphous Calcium Phosphate Dental Paste

Application of CPP-ACP on one premolar once every 2 weeks for 3 months.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Maha Swelam, Bachelor · Department of orthodontics

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-31
Primary Completion
2017-09-30
Completion
2018-01-31
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03187548 on ClinicalTrials.gov